Tracking the Secrets of the Brain

Erich R. ReinhardtErich Reinhardt, member of the Managing Board of Siemens AG and president and CEO of Siemens Medical Solutions, has been awarded the International Neurobionics Award 2006 in the amount of 25,000 Euro by the International Neurobionics Foundation. Erich R. Reinhardt would like to promote young scientists with his prize money.

The modern science of neurobionics connects neurosciences, biology and applied medical engineering to develop new medical procedures that reestablish destroyed nerve paths or nerve contacts after illnesses or accidents. The International Neurobionics Foundation provides financial and conceptual support to projects that help people who are blind, deaf or paralyzed to fully or partially regain their lost sense or mobility through the use of modern microchip implantation. The foundation promotes groundbreaking work in the interdisciplinary field of neurobionics. Since 1998, it also awards outstanding pioneers and personalities of the various neurobionic disciplines with the International Neurobionics Award in the area of biomedical research and technology that serve for rehabilitation, implementation or restoration of neurological functions.

Erich R. Reinhardt has been honored with the international award for his efforts in the area of imaging methods. According to Madjid Samii, President of the Senate of the International Neurobionics Foundation, without these activities the extraordinary recent successes in neurosurgery would not have been possible. Reinhardt accepted the award in the name of the Med Group's work: "I am very happy about this award. It shows me that we are not only facilitating high-quality, patient-oriented medical care but also fostering research for future generations."

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting www.siemens.com/medical

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...